Oral Contraceptive Pills Market
Number of pages: 100 | Report Format: PDF | Published date: 03 March, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market size value in 2022 |
US$ 17.9 billion |
|
Revenue Forecast in 2031 |
US$ 33.7 billion |
|
Growth Rate |
CAGR of 7.25% from 2023 to 2031 |
|
Base year for estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Drug Type, Distribution Channel, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
According to the deep-dive market assessment study by Growth Plus Reports, the global oral contraceptive pills market was valued at US$ 17.9 billion in 2022 and is expected to register a revenue CAGR of 7.25% to reach US$ 33.7 billion by 2031.
Market Fundamentals
Oral contraceptive pills or birth control pills offer women and couples a variety of alternatives to delay, terminate, and limit pregnancies. This is the most widely used method of contraception. Moreover, the method is 99% effective in preventing pregnancies when taken correctly. Excess use of contraceptive pills lead to delay in the menstrual cycle, and cramps associated with the period, as well as the risk of ovarian cysts and the appearance of acne.
Oral contraception is often recommended for four weeks, with each four-week package comprising four to seven days of hormone-free tablets. During these hormone-free days, women have their periods. Certain medications provide "extended" or "continuous" hormone doses with fewer or no hormone-free days, allowing women to have their periods less than once a month. Currently, there are three different forms of oral contraceptive pills, continuous or prolonged use pills, progesterone-only or progestin-only pills, and combination estrogen-progesterone pills. Combined oral contraceptive pills contains artificial forms of female hormones such as estrogen and progesterone. Combined oral contraceptive comes in two forms monophasic and multiphasic. Monophasic contraceptive pills are most commonly preferred combination contraceptive pills. Monophasic contraceptive tablet has same quantity of hormones. Microgynon, Marvelon, and Yasmin are common examples of monophasic pills.
[46345634]
Market Dynamics
The high demand for oral contraceptive pills among reproductive-age people is the major factor increasing the global oral contraceptive pills market. According to the National Library of medicine in the United States, the birth control pill is the most widely recommended method of contraception. Around 25% of women aged 15 to 44 using contraception presently report choosing contraception pill as their preferred choice. This is majorly due to its easy accessibility and high efficacy. Moreover, contraceptive pills are also demanding in low and middle-income countries. According to the 2019 estimates by the United Nations data booklet “contraceptive use by the method”, about 10.5 percent of women in Northern Africa and Western Asia use oral contraceptive pills as their first choice of contraception.
The market for oral contraceptive pills is anticipated to rise over the forecast years due to the increasing rate of unwanted births. According to research conducted by the University of California, San Francisco (UCSF), when women obtained a one-year prescription for oral contraceptives, the rates of unplanned pregnancy and abortion decreased significantly. Every year, 74 million women in low-middle-income nations have unwanted pregnancies, according to the World Health Organization (WHO), around 4,794 women experienced unintended pregnancies after stopping their use of contraception. As a result, the urge to avoid unexpected births promotes the rise of the market for oral contraceptive tablets.
Moreover, increasing government initiatives for contraception is another factor influencing the global oral contraceptive pills market. For instance, In September 2022, the ministry of health in Ireland launched a free contraception scheme for women aged 17-25. The government supported the scheme with 9 Euro million in the 2022 budget. This free contraception plan will cover the cost of prescribed contraception, as well as the cost of visits with general practitioners and other qualified medical experts who will discuss available contraceptive methods with eligible patients and write prescriptions for them.
However, the health risks associated with contraceptive use, the availability of alternative contraceptive methods, and lower social acceptance are limiting the global oral contraceptive pills revenue growth of the oral contraceptive market.
Market Ecosystem
The global oral contraceptive pills market has been analyzed from four perspectives: Drug Type, Distribution Channel, and Region
Oral contraceptive pills market by Drug Type
[6734534]
Based on drug type, the global oral contraceptive pills market has been segmented into combined pills, extended/continuous use, progestin-only, and emergency contraceptive pills.
Progestin only drugs accounted majority of market revenue share in 2022. This is owing to its high efficacy rate. Additionally, progestin-only contraceptive pills are safe to use even during the lactation period as it does not suppress breast milk production. Moreover, progestin-only contraceptive drugs are also beneficial in women who have contraindications to use estrogen such as progestin only drugs can be safely taken by people with certain cardiac disorders, such as a tendency for blood clots, who are advised against using combination pills. Progestin pills are not associated with a rise in blood pressure or cardiovascular disease.
Furthermore, progestin can also help in improving menstrual conditions. Since progestin thins the uterine lining, there is less lining to shed, which results in lighter periods, a decrease in severe premenstrual symptoms, and less cramping for the majority of women who use progestin-only tablets.
The combination contraceptive drugs segment is anticipated to grow in the forecast period. This is attributed to the increasing demand for combination drugs. Additionally, combination oral contraceptive formulations and pill-taking patterns have improved over time, preserving contraceptive effectiveness while also being safer and more tolerable. The use of combination oral contraception offers users a number of important non-contraceptive advantages in addition to pregnancy prevention.
The demand for emergency contraceptive pills is growing significantly. This is majorly attributed to increasing awareness related to its efficacy. Additionally, emergency oral contraceptive pills are suitable for women who cannot use oral combination contraceptive pills.
Oral contraceptive pills market by Distribution Channel
Based on distribution channels, the global oral contraceptive pills market has been segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
The retail pharmacies segment accounted for the largest revenue share in 2022. This is attributed to taking oral contraceptive pills from retail pharmacies including convenient access to medication, potentially lower costs, and increased privacy. Additionally, many retail pharmacies offer counseling and education services to help patients better understand their medication and how to use it effectively. Overall, obtaining oral contraceptive pills from a retail pharmacy can be a great option for those looking for a convenient and affordable way to manage their reproductive health.
The online pharmacies segment is anticipated to experience high growth in the forecast period. This is attributed to lower and discounted prices of contraceptive drugs offered by online pharmacies than traditional pharmacies.
Oral contraceptive pills market by Region
Based on region, the global oral contraceptive pills market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America accounted for largest revenue share in the global contraceptive pills market in 2022 owing to the high demand for contraceptive pills in the region. This is attributed to increased awareness about its efficacy and accuracy. Moreover, according to the National Library of Medicine, In the US, the birth control pill is frequently prescribed method of birth control. Moreover, in several states, contemporary advocacy and legislative initiatives have been directed at increasing access to oral contraceptives by getting rid of the requirement that women first attend an in-person clinician consultation. Furthermore, the global contraceptive pills market in North America is also led by increasing per capita income, increasing awareness, and a high prevalence of unintended pregnancies.
Moreover, Europe held the second-largest market revenue share. One of the primary reasons driving the market in the region is the widespread awareness and easy accessibility of drugs. Furthermore, the government and NGOs are taking initiatives to increase awareness of contraceptive pills. The government has implemented a variety of educational initiatives emphasizing the significance of birth control, because of the growing population.
Additionally, Asia Pacific is one of the fastest-growing regions during the forecast period. This is majorly due to high demand od contraceptive pills the region is dealing with a significant rise in population, especially in emerging nations like China and India. Governments in this region have developed programs to raise awareness about family planning and birth control. The widespread availability of OTC oral contraceptive pills is driving the contraception market in the Asia Pacific.
Competitive Landscape
Some of the prominent market players in the global oral contraceptive pills market include:
Strategic Development
The global oral contraceptive pills market was valued at US$ 17.9 billion in 2022.
North America is the key growth region in the global oral contraceptive pills market.
The top five players in the global oral contraceptive pills market are AbbVie, Inc., Pfizer, Inc., Merck & Co., Inc., Bayer AG, and Teva Pharmaceuticals Industries.
The progestin only contraceptive pills led the global oral contraceptive pills market.
The estimated market size of the global oral contraceptive pills market in 2031 is 33.7 billion.
*Insights on financial performance are subject to the availability of information in the public domain
Using the fundamental research and knowledge services capabilities of GRG Health, Growth Plus Reports may now be tailored based on client needs.
GRG Health's unique GrowthMIX strategy and comprehensive research methodology enable us to provide unique and valuable insights to our clients while uncovering trends that would not be discovered using traditional techniques.
Snehal Deshmukh
Principle Consultant
Speak to analyst